Advanced Medical Solutions Group (LON:AMS) Issues Earnings Results

Advanced Medical Solutions Group (LON:AMS) released its quarterly earnings results on Wednesday. The company reported GBX 11.98 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Advanced Medical Solutions Group had a return on equity of 3.69% and a net margin of 4.16%.

Advanced Medical Solutions Group Price Performance

LON:AMS opened at GBX 199.15 on Thursday. The stock has a market capitalization of £430.93 million, a PE ratio of 47.76, a P/E/G ratio of 5.00 and a beta of 0.60. Advanced Medical Solutions Group has a 1-year low of GBX 168.40 and a 1-year high of GBX 248.50. The firm has a fifty day simple moving average of GBX 212.50 and a 200 day simple moving average of GBX 214.38. The company has a current ratio of 2.88, a quick ratio of 4.58 and a debt-to-equity ratio of 32.15.

Analysts Set New Price Targets

Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a research report on Wednesday. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of GBX 273.67.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.